Sigma Pharmaceuticals Limited - SWOT, Strategy and Corporate Finance Report
Published: February 2013 · Publisher: MarketLine
Sigma Pharmaceuticals Limited - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Sigma Pharmaceuticals Limited - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sigma Pharmaceuticals Limited including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Sigma Pharmaceuticals Limited
- Intelligence on Sigma Pharmaceuticals Limitednv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sigma Pharmaceuticals Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Sigma Pharmaceuticals Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Sigma Pharmaceuticals Limited - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Sigma Pharmaceuticals (Sigma) is a leading wholesaler and distributor of pharmaceutical products in Australia. The company also operates in New Zealand and Hong Kong. It is headquartered in Rowville, Victoria, Australia. The company recorded revenues of A$2,914.3 million ($2,700.4 million*) from its continuing operation in the financial year ended January 2011 (FY2011), an increase of 6.6% over FY2010. The company's operating profit was A$60.3 million ($55.9 million*) in FY2011, a decrease of 11.7% compared with FY2010. The net loss was A$235.4 million ($218.1 million*) in FY2011 as compared to a net loss of A$398.3 million ($369.1 million*) in FY2010. *Calculated using the constant conversion rate of A$1 = $0.9266 for the financial year ended January 31, 2011.
Scope of the Report
- Provides all the crucial information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Sigma Pharmaceuticals Limited
-Data is supplemented with details on Sigma Pharmaceuticals Limited history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Sigma Pharmaceuticals Limited
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Reasons to Purchase:
- Gain understanding of Sigma Pharmaceuticals Limited and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sigma Pharmaceuticals Limited as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Sigma Pharmaceuticals Limited’s business structure, strategy and prospects
Features:
- Detailed information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sigma Pharmaceuticals Limited including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Sigma Pharmaceuticals Limited
- Intelligence on Sigma Pharmaceuticals Limitednv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sigma Pharmaceuticals Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Sigma Pharmaceuticals Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Sigma Pharmaceuticals Limited - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Sigma Pharmaceuticals (Sigma) is a leading wholesaler and distributor of pharmaceutical products in Australia. The company also operates in New Zealand and Hong Kong. It is headquartered in Rowville, Victoria, Australia. The company recorded revenues of A$2,914.3 million ($2,700.4 million*) from its continuing operation in the financial year ended January 2011 (FY2011), an increase of 6.6% over FY2010. The company's operating profit was A$60.3 million ($55.9 million*) in FY2011, a decrease of 11.7% compared with FY2010. The net loss was A$235.4 million ($218.1 million*) in FY2011 as compared to a net loss of A$398.3 million ($369.1 million*) in FY2010. *Calculated using the constant conversion rate of A$1 = $0.9266 for the financial year ended January 31, 2011.
Scope of the Report
- Provides all the crucial information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Sigma Pharmaceuticals Limited
-Data is supplemented with details on Sigma Pharmaceuticals Limited history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Sigma Pharmaceuticals Limited
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Reasons to Purchase:
- Gain understanding of Sigma Pharmaceuticals Limited and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sigma Pharmaceuticals Limited as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Sigma Pharmaceuticals Limited’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Sigma Pharmaceuticals Limited: Company Overview
Sigma Pharmaceuticals Limited: Overview and Key Facts
Sigma Pharmaceuticals Limited: Overview
Sigma Pharmaceuticals Limited: Key Facts
Sigma Pharmaceuticals Limited: Key Employees
Sigma Pharmaceuticals Limited: Key Employee Biographies
Sigma Pharmaceuticals Limited: Major Products and Services
Sigma Pharmaceuticals Limited: Company History
Sigma Pharmaceuticals Limited: Management Statement
Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Sigma Pharmaceuticals Limited: Key Competitors
Sigma Pharmaceuticals Limited: Company Analysis
Sigma Pharmaceuticals Limited: Business Description
Sigma Pharmaceuticals Limited: SWOT Analysis
Sigma Pharmaceuticals Limited: SWOT Overview
Sigma Pharmaceuticals Limited: Strengths
Sigma Pharmaceuticals Limited: Weaknesses
Sigma Pharmaceuticals Limited: Opportunities
Sigma Pharmaceuticals Limited: Threats
Sigma Pharmaceuticals Limited: Corporate Financial Deals Activity
Sigma Pharmaceuticals Limited: Financial Deals Overview
Sigma Pharmaceuticals Limited: Targets and Partners
Sigma Pharmaceuticals Limited: Top Deals 2009 - 2013YTD*
Sigma Pharmaceuticals Limited: Advisors
Sigma Pharmaceuticals Limited: Top Legal Advisors
Sigma Pharmaceuticals Limited: Top Financial Advisors
Sigma Pharmaceuticals Limited: Mergers and Acquisitions
Sigma Pharmaceuticals Limited: Capital Raising
Sigma Pharmaceuticals Limited: Partnership
Sigma Pharmaceuticals Limited: Divestments
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Sigma Pharmaceuticals Limited: Key Facts
Table 2: Sigma Pharmaceuticals Limited: Key Employees
Table 4: Sigma Pharmaceuticals Limited: Key Competitors
Table 5: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Table 7: Sigma Pharmaceuticals Limited: Targets and Partners
Table 8: Sigma Pharmaceuticals Limited: Top Deals 2009 - 2013YTD*
Table 9: Sigma Pharmaceuticals Limited: Legal Advisor Ranking by Value (US$m)
Table 10: Sigma Pharmaceuticals Limited: Financial Advisor Ranking by Value (US$m)
Table 11: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2009 - YTD*2013)
Table 12: Sigma Pharmaceuticals Limited: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 13: Sigma Pharmaceuticals Limited: Capital Raising by Deal Type (2009 - YTD*2013)
Table 14: Sigma Pharmaceuticals Limited: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 15: Sigma Pharmaceuticals Limited: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 16: Sigma Pharmaceuticals Limited: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 17: Sigma Pharmaceuticals Limited: Divestments by Geography (2009 - YTD*2013)
List of Figures
Figure 1: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 2: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Figure 3: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 4: Sigma Pharmaceuticals Limited: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 5: Sigma Pharmaceuticals Limited: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 6: Sigma Pharmaceuticals Limited: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 7: Sigma Pharmaceuticals Limited: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 8: Sigma Pharmaceuticals Limited: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 9: Sigma Pharmaceuticals Limited: Divestments by Geography (2009 - YTD*2013)
Sigma Pharmaceuticals Limited: Company Overview
Sigma Pharmaceuticals Limited: Overview and Key Facts
Sigma Pharmaceuticals Limited: Overview
Sigma Pharmaceuticals Limited: Key Facts
Sigma Pharmaceuticals Limited: Key Employees
Sigma Pharmaceuticals Limited: Key Employee Biographies
Sigma Pharmaceuticals Limited: Major Products and Services
Sigma Pharmaceuticals Limited: Company History
Sigma Pharmaceuticals Limited: Management Statement
Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Sigma Pharmaceuticals Limited: Key Competitors
Sigma Pharmaceuticals Limited: Company Analysis
Sigma Pharmaceuticals Limited: Business Description
Sigma Pharmaceuticals Limited: SWOT Analysis
Sigma Pharmaceuticals Limited: SWOT Overview
Sigma Pharmaceuticals Limited: Strengths
Sigma Pharmaceuticals Limited: Weaknesses
Sigma Pharmaceuticals Limited: Opportunities
Sigma Pharmaceuticals Limited: Threats
Sigma Pharmaceuticals Limited: Corporate Financial Deals Activity
Sigma Pharmaceuticals Limited: Financial Deals Overview
Sigma Pharmaceuticals Limited: Targets and Partners
Sigma Pharmaceuticals Limited: Top Deals 2009 - 2013YTD*
Sigma Pharmaceuticals Limited: Advisors
Sigma Pharmaceuticals Limited: Top Legal Advisors
Sigma Pharmaceuticals Limited: Top Financial Advisors
Sigma Pharmaceuticals Limited: Mergers and Acquisitions
Sigma Pharmaceuticals Limited: Capital Raising
Sigma Pharmaceuticals Limited: Partnership
Sigma Pharmaceuticals Limited: Divestments
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Sigma Pharmaceuticals Limited: Key Facts
Table 2: Sigma Pharmaceuticals Limited: Key Employees
Table 4: Sigma Pharmaceuticals Limited: Key Competitors
Table 5: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Table 7: Sigma Pharmaceuticals Limited: Targets and Partners
Table 8: Sigma Pharmaceuticals Limited: Top Deals 2009 - 2013YTD*
Table 9: Sigma Pharmaceuticals Limited: Legal Advisor Ranking by Value (US$m)
Table 10: Sigma Pharmaceuticals Limited: Financial Advisor Ranking by Value (US$m)
Table 11: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2009 - YTD*2013)
Table 12: Sigma Pharmaceuticals Limited: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 13: Sigma Pharmaceuticals Limited: Capital Raising by Deal Type (2009 - YTD*2013)
Table 14: Sigma Pharmaceuticals Limited: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 15: Sigma Pharmaceuticals Limited: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 16: Sigma Pharmaceuticals Limited: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 17: Sigma Pharmaceuticals Limited: Divestments by Geography (2009 - YTD*2013)
List of Figures
Figure 1: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 2: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Figure 3: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 4: Sigma Pharmaceuticals Limited: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 5: Sigma Pharmaceuticals Limited: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 6: Sigma Pharmaceuticals Limited: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 7: Sigma Pharmaceuticals Limited: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 8: Sigma Pharmaceuticals Limited: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 9: Sigma Pharmaceuticals Limited: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.